To further demonstrate that ASIC1/3 facilitated aggressive behavior of pancreatic cancer cells in vivo, we next used BxPC-3 cells to establish tumor xenografts with stable knockdown of ASIC1 and ASIC3, respectively. This evidence concerns the gene ASIC1 and pancreatic neoplasm.